ALZN · Alzamend Neuro, Inc. · Analyst Estimates
$1.84
+0.01 (+0.55%)
At close · Sep 17
Going-concern doubt
— flagged Sep 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors create substantial doubt about our ability to continue as a going concern for at least one year after the date that our condensed financial statements are issued.”View the 10-Q filed Sep 10, 2026
Market Cap
$8.59M
Shares
4.83M
Analyst Estimates
Compare analyst forecasts for Alzamend Neuro, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.
No published consensus found
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.